Carton30ml (Carton30ml)
This is not readable text.*
Ciclopirox Olamine
Product Images NDC 69315-309
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ciclopirox Olamine (NDC 69315-309). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Leading Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Carton60ml (Carton60ml)
The text is a description of a medicinal product containing Ciclopirox in a water-based suspension. It provides information about the quantity of Ciclopirox in each gram of the suspension, along with details about the ingredients in the suspension base. It also mentions the temperature at which the product should be stored. The remaining portions of the text appear to be nonsensical and may be the result of errors.*
Image Description (Chemicalstructure)
Containerlabel30ml (Containerlabel30ml)
This is a prescription-only topical suspension medication called Ciclopirox. It is not for use in the eyes and should be kept out of reach of children. The suspension is water-miscible and contains Ciclopirox Olamine as its active ingredient. It is to be applied twice daily and massaged into the affected and surrounding skin areas. This medication is manufactured for Leading Pharma LLC and made by Teigent Pharma Inc. It is advised to read the package insert for full prescribing information.*
Containerlabel60ml (Containerlabel60ml)
This is a prescription drug with NDC (National Drug Code) number 69315-309-60. It is a 60 mL topical suspension of Ciclopirox that is meant for external use only and should not be applied to the eyes. The packaging includes cautionary instructions for keeping it out of reach of children. The manufacturer is identified as Leading Pharma, and the revision date of the medication's information is April 2020.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
